How A.I. Is Revolutionizing Drug Development
nytimes.com
nytimes.com
Designing potential drugs is nice an all, but the thing that would make drug develompent more effective would be predicting if those drugs will make it through phase III of the clinical trials.
in silico insight is already being used to reduce the amount of wet lab work that needs to be done at each step of the process
predict safety (phase 1) and efficacy (phase 2). phase 3 is just a confirmation vs competitive drugs